Ruti Aga's Six-Year Ban: Two Years for a Drug, Four for a Document, and a Clinic That Never Existed

From 10 September, six years are entered against Ruti Aga's name. Two of those years belong to a drug and four belong to the piece of paper that was manufactured to make the drug look legitimate. The Athletics Integrity Unit's statement on Thursday leads with that sum, and the arithmetic of the sum is the single most useful piece of information in the case. Six years is not the sentence for one offence. It is the addition of two separate violations, and the addition tells us that the panel did not accept intent on the substance charge but treated the paperwork charge as fully culpable.

Her sample turned positive after she won a half marathon in China in March. A knee injury was cited. A prescription was produced in the name of treatment, and that prescription was written on the letterhead of a clinic that did not exist. The "doctor" who wrote it was a family member with no medical registration, who then tried to escape by claiming he had used "an old prescription pad from a former workplace." The AIU checked all three links separately and got the same answer each time: no clinic, no registration, no pad.

This piece is not about the moment the sample came back positive. It is about the twelve months in which a 32-year-old marathoner had one legitimate defence available to her and closed it with a document. In 32 years of reporting I have read hundreds of doping files, and the pattern repeats: the substance charge is worth two years, and the clean-up afterwards ends the career. That is exactly what happened here.

The numbers behind the roar: the drug was not a steroid

Start with the technical error that travelled furthest. Media reports described methylprednisolone as a "prohibited steroid" and said WADA classifies it as performance enhancing. Both descriptions are incomplete. Methylprednisolone is a glucocorticoid, class S9 on the WADA Prohibited List. It is not an anabolic steroid (class S1). Under the current List, S9 glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes.

The distinction is not semantic. It moves the entire case to a different place. Had this been an anabolic steroid, the defence door would have been nearly shut. Because it is a glucocorticoid, the door was open, and it opened on two hinges: route and timing. A knee injection given days before a race, out of competition, is entirely legal. The same injection still present in the body on race day is a violation. That is the legal fulcrum of the case.

In road racing the testing window opens at 23:59 the day before the race. An injection given four or five days out is still caught if residue remains on race day. Aga had one clean path: genuine medical records, the date of the injection, the route, the dose, and a clinician's written opinion. Instead of walking that path she manufactured paper, and the moment the paper appeared the path closed.

The media error costs more than Aga. When a glucocorticoid case is written in the language of steroids, the reader's mind converts it into a different category of offence, the kind in which an athlete cheats for competitive advantage. The question here was procedural, not competitive. A procedural error deserved a procedural sanction. The language in which the story spread had already justified the sentence before the sentence was explained.

Two plus four: the sentence explains itself

The arithmetic buried in the first paragraph: two years for the presence violation, four years for tampering, six years total.

The two-year figure is itself information. Under the WADA Code, for a Specified Substance, where intent is not established and the athlete offers some explanation, the standard sanction can fall below two years. Aga received two, which means the panel heard her explanation and declined to place it in the No Significant Fault category. The knee-injury account was physiologically plausible — intra-articular methylprednisolone for knee synovitis is standard sports medicine in distance running — but once paper was produced to support the account, the account lost its credibility.

The four-year figure is blunter. That is the Code's standard tampering sanction, and the panel granted no reduction. Which produces the paradox few people notice: forged documentation is itself circumstantial evidence of concealment intent, yet it did not escalate the substance sanction. The two penalties sat in their own boxes without affecting each other. The panel appears to have treated the file as two facts: a substance was present in the body, and investigators were misled.

One confusion about the 10 September date needs clearing. The ban was backdated to the provisional suspension. That is bookkeeping, not relief. Every month she had already spent out of the sport was folded into the sentence. She gained nothing in real terms. The statement does not give the year of expiry, nor the year of the March race. That gap is a weakness of the file, and I am recording it deliberately, because an inference should never be printed as a fact.

Three verifications, three failures

The forged prescription is not a mistake. It is a chain, and every link broke in a different place.

Link one: the clinic. The clinic named on the prescription did not exist. Link two: the doctor. The person who wrote it was a family member with no medical registration. Link three: the pad. He claimed to have used an old prescription pad from a former workplace, and that workplace disowned the claim.

Three separate institutions gave three separate answers, and all three pointed the same way. A single lapse would have left at least one link intact. All three breaking tells us the forger did not know what a real prescription contains — clinic address, registration number, patient identifier, dose, route, signature, stamp. That ignorance is evidence of the thing the AIU never wrote down: this athlete had no credentialed team physician.

That is the root of the case, and it is structural rather than personal. When I moved from the newsroom into sports management in 2026, the first thing that became obvious was that an athlete's medical support matters as much as the quality of her training. In a functioning system, a knee injury produces three things — a clinical examination, a written record, and a treatment date set against the competition calendar. None of the three exists in this file. What exists is a relative writing a slip.

The participation ledger: how many marathoners have a doctor?

This is the question nobody can answer, and that is precisely why it matters.

When I launched The Gender Gap newsletter in 2026, the first edition covered the Asian Athletics Championships in Bhubaneswar. India won 29 medals there and 12 belonged to women; the women's 4x400m relay took gold in 3:31.34. I interviewed all four of them and then counted the coverage. Athletes who won 41 per cent of the medals received 18 per cent of the media mentions. That is the same method I am applying here.

The participation question is not how many Ethiopian women run under 2:20. It is how many of them have a registered team physician named against their file, how many have treatment records stored on a server, and how many have ever filed a TUE themselves. That number is published nowhere, because it is not a performance number. And the number that is never published is the one that matters most.

There is a technical wrinkle worth understanding. For glucocorticoids the in-competition TUE route is narrow — injectable routes are not covered. Aga did not have the easy option of "just get a TUE." What she had was clean documentation and correct washout timing. The medical-governance gap therefore cut twice: there was no legitimate treatment record, and a legitimate treatment record was the only defence that could have worked.

The appearance-fee economy and the testing economy

The March half marathon in China is the least discussed and most revealing part of the story.

Road racing has a tier that sits between the Majors and the championships: World Athletics Label road races. Appearance-fee budgets there are large, East African elite fields are dense, and the status is high enough that testing happens. For East African marathoners this tier is invaluable — a reliable income source between Majors that does not load the body the way a Major does.

It is also where AIU testing density is highest. Two economies collide inside the same race: the one paying fees and the one collecting samples. The race an athlete selects for income is the race a regulator selects for surveillance. The consequence is that results at this tier will carry integrity risk alongside performance pressure.

One correction is necessary, because coverage of this case inflated it. The statement says she won the half marathon. That is all. No time, no splits, no field strength, no conditions. Where there is no time, performance analysis becomes guesswork, and calling guesswork analysis is the oldest habit in this trade. I will not indulge it.

The age line and the value of a career

Aga is 32. The six-year ban runs from 10 September. The arithmetic is simple: return at roughly 38.

Thirty-eight is not automatically fatal in the marathon; some athletes still run under 2:25 at that age. But in Ethiopian women's marathon, 38 means something else. Depth there is such that a 2:18 performer cannot assume selection. In that environment a 38-year-old with a doping record on file is practically unselectable. The ban is six years on paper and career-terminal in practice.

Two kinds of numbers must be kept apart here, because the temptation to merge them is strong. The podium metric says: 2026 Tokyo Marathon title, three second places at World Marathon Majors. The participation metric says: she belonged to the cohort that converted Ethiopian domestic depth into international presence, without a global championship medal. The first measures her career's value. The second measures how much her absence changes Ethiopia's medal capacity — almost nothing.

That is the correct frame for this story. It is not a medal story. It is a payroll and administration story. The exit of a 32-year-old with no global championship medal does not move the sport's competitive balance. What it does reveal is how thin the support structures are for the people working inside that circuit.

What survives and what does not: the disqualification scope

The statement does not say which results were annulled. A reader will skip that omission; a professional cannot.

Standard practice is that the competition where the sample was collected is disqualified, along with its prize money. The March half marathon, its title, its fee — all likely gone. Ranking points accrued after that date are likely gone too.

On the other side sits what does not go. The violation is anchored to the March race. Unless the panel found earlier use, results before that date are not automatically annulled. The 2026 Tokyo title, the Berlin second place, the rest of the Major record survive in the books.

Her record therefore splits in two. On one side, the athlete who won Tokyo and ran in the 2:18 range — I watched her in Berlin 2026 and Tokyo 2026, and her defining quality in that race was that she did not lose rhythm through the middle kilometres. On the other, the athlete whose name sits in a doping file. Both are true, and erasing either one is a disservice to both.

Here I have to avoid the 2026 trap. The Delhi Commonwealth Games get written up as a golden age with the 2026 doping asterisk quietly dropped, and the same temptation exists here — either to erase an entire career with one prescription, or to bury the prescription under the career's shine. Neither is reporting.

The attention audit: which story travels faster

During the 2026 World Cup I published a piece asking what women's sport would look like with one per cent of the tournament's coverage. It was shared 10,000 times, and a #EqualPlay Twitter chat with 500 participants trended in India for two hours. That experience taught me something that applies directly here: a mislabelled story travels faster than an accurately labelled one.

"Marathon runner banned six years in steroid case" spreads in an hour. "Marathon runner banned six years for timing failures around a glucocorticoid injection and subsequent document tampering" demands effort, so it spreads less. The bitterness of the sanction arrives; the reason for it does not.

Set a second number against that. How much space did winning Tokyo in 2026 get her? Winning a Major is the biggest achievement in this sport. How much space did a prescription get? I do not have an instrument that measures both on the same scale, so I will not invent the figure. But what I counted in Bhubaneswar in 2026 applies: 41 per cent of the medals, 18 per cent of the mentions. The ratio's architecture is unchanged; only the unit has shifted. We used to count medals. Now we count sanctions.

The contrarian angle: equal sentence, unequal capacity

Here is the part of this case that will be written about least and thought about most.

An athlete with a registered team physician, an English-speaking agent, digitised treatment records, and the ability to hold her ground in an AIU interview reaches a different outcome from the same situation. She has a document with the injection date, the route and the dose. She avoids or sharply reduces the two-year sanction. She is never charged with tampering, because she never needs to tamper.

On the other side is an athlete with none of those four things. She has a relative who writes a slip.

The sentence falls equally on both. The capacity to bear it does not. Saying this does not excuse the forgery — fabricating a document is a serious offence and should be punished. It says that the enforcement frontier has moved. The fight used to be in the laboratory: was the substance there. The fight is now in the paperwork: is the document real. That shift is rational, because paper is cheap and easy to make. Its side effect is that athletes without formal support structures fall first at the new frontier.

A second gap is visible. The statement names only the family member. It does not say whether any agent, manager or coach was investigated. Somebody advised on that document, somebody accepted it, somebody placed it in front of the AIU. A system in which the athlete is the sole culprit and the adviser is invisible will repeat the same event.

A third absence is worth recording. This statement is AIU only. There is no Ethiopian federation statement, no national-level response. That silence is information too, because a strong national structure would at least explain why an athlete lacked medical support.

What comes next: three small asks

An appeal route exists, and anyone who understands the file knows what it would target. The document finding rests on paperwork, and paper findings are hard to overturn. More important than the appeal is disclosure.

My first ask is small: publish the disqualification scope. Which race result was annulled, which prize money is being recovered, and from which date forward earlier results remain untouched. This matters for the truth of the record, not for the public's curiosity.

Second: the AIU should issue a plain-language technical note on how the defence works in route-and-timing glucocorticoid cases. Right now neither the athlete nor her entourage understands the rule, and not understanding it can cost six years.

Third, and most important: make a registered team physician mandatory for elite women entering Label road races, the way medication and sample declarations already are. It is a form, not a revolution. Had the form existed, Aga would have had no reason to make that slip.

The next time a marathoner stands on a start line with a sore knee, the question should not be which injection she took. It should be who wrote it, and in which register that name is recorded.